(Q41598543)

4 October 2017

1 reference

title

Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls (English)

1 reference

4 October 2017

E S Robinson

1

1 reference

4 October 2017

D J Nutt

series ordinal

2

1 reference

4 October 2017

H C Jackson

series ordinal

3

1 reference

4 October 2017

A L Hudson

series ordinal

4

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Journal of Psychopharmacology

4 October 2017

published in

1 reference

4 October 2017

volume

11

1 reference

4 October 2017

issue

3

1 reference

4 October 2017

page(s)

259-269

1 reference

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

The application of antisense oligonucleotide technology to the brain: some pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

The role of the amygdala in fear and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Characterization of oxytocin-binding sites in primary rat brain cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Cloning of a delta opioid receptor by functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Control of oncogene expression by antisense nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligonucleotide to GABAA receptor gamma 2 subunit induces loss of neurones in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Inhibition of Herpes Simplex Virus Replication by Antisense Oligo-2'-O-methylribonucleoside Methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Measles virus antisense sequences specifically cure cells persistently infected with measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Brain mechanisms of emotion and emotional learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Excitatory amino acids in epilepsy and potential novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Excitatory amino acid neurotoxicity and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Cloning and pharmacological characterization of a rat kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Biochemical and biological effects of nonionic nucleic acid methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

c-fos expression in the amygdala: in vivo antisense modulation and role in anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Gene inhibition using antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligonucleotide strategies in neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Role of RNase H in hybrid-arrested translation by antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Specificity of antisense oligonucleotides in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Bone and haematopoietic defects in mice lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

BCR-ABL antisense purging in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100310

10.1177/026988119701100310

21 January 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference